25 XP   0   0   10

ANI Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse ANI Pharmaceuticals Inc together

PenkeI guess you are interested in ANI Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ANI Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ANI Pharmaceuticals Inc

I send you an email if I find something interesting about ANI Pharmaceuticals Inc.

Quick analysis of ANI Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of ANI Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.08
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
$20.63
Expected worth in 1 year
$25.12
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
$4.57
Return On Investment
7.0%

For what price can you sell your share?

Current Price per Share
$64.95
Expected price per share
$54.62 - $70.81
How sure are you?
50%

1. Valuation of ANI Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$64.95

Intrinsic Value Per Share

$22.60 - $70.23

Total Value Per Share

$43.22 - $90.85

2. Growth of ANI Pharmaceuticals Inc (5 min.)




Is ANI Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$432.7m$339.5m$75.7m18.2%

How much money is ANI Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money$4.6m-$11.9m$16.6m355.1%
Net Profit Margin3.8%-16.5%--

How much money comes from the company's main activities?

3. Financial Health of ANI Pharmaceuticals Inc (5 min.)




What can you expect buying and holding a share of ANI Pharmaceuticals Inc? (5 min.)

Welcome investor! ANI Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of ANI Pharmaceuticals Inc.

What can you expect buying and holding a share of ANI Pharmaceuticals Inc?

First you should know what it really means to hold a share of ANI Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of ANI Pharmaceuticals Inc is $64.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ANI Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ANI Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $20.63. Based on the TTM, the Book Value Change Per Share is $1.12 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ANI Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.060.1%0.210.3%-0.59-0.9%-0.22-0.3%-0.03-0.1%
Usd Book Value Change Per Share-1.05-1.6%1.121.7%-0.24-0.4%0.560.9%0.470.7%
Usd Dividend Per Share0.020.0%0.020.0%0.020.0%0.010.0%0.000.0%
Usd Total Gains Per Share-1.03-1.6%1.141.8%-0.22-0.3%0.570.9%0.470.7%
Usd Price Per Share55.14-51.69-32.54-45.23-48.01-
Price to Earnings Ratio250.40-132.77--20.36-188.38-125.21-
Price-to-Total Gains Ratio-53.67-158.84-1,433.54-129.68-329.18-
Price to Book Ratio2.67-2.60-2.01-3.76-5.29-
Price-to-Total Gains Ratio-53.67-158.84-1,433.54-129.68-329.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share64.95
Number of shares15
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share1.120.56
Usd Total Gains Per Share1.140.57
Gains per Quarter (15 shares)17.138.56
Gains per Year (15 shares)68.5234.25
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11675913424
2213512816758
33202197210192
452692662135126
563373353168160
674044043202194
784714734236228
895395425269262
9106066115303296
10126746806337330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%5.07.00.041.7%9.011.00.045.0%26.014.00.065.0%30.066.00.031.3%
Book Value Change Per Share3.01.00.075.0%6.06.00.050.0%11.09.00.055.0%29.011.00.072.5%50.045.01.052.1%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%12.00.08.060.0%12.00.028.030.0%12.00.084.012.5%
Total Gains per Share3.01.00.075.0%7.05.00.058.3%12.08.00.060.0%30.010.00.075.0%51.044.01.053.1%

Fundamentals of ANI Pharmaceuticals Inc

About ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Fundamental data was last updated by Penke on 2024-04-11 00:39:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of ANI Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ANI Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.9% means that $0.01 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ANI Pharmaceuticals Inc:

  • The MRQ is 0.9%. The company is not making a profit/loss.
  • The TTM is 3.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ0.9%TTM3.8%-2.9%
TTM3.8%YOY-16.5%+20.3%
TTM3.8%5Y-8.1%+11.9%
5Y-8.1%10Y2.4%-10.5%
1.1.2. Return on Assets

Shows how efficient ANI Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.1% Return on Assets means that ANI Pharmaceuticals Inc generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ANI Pharmaceuticals Inc:

  • The MRQ is 0.1%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM0.5%-0.4%
TTM0.5%YOY-1.6%+2.1%
TTM0.5%5Y-0.7%+1.3%
5Y-0.7%10Y0.3%-1.0%
1.1.3. Return on Equity

Shows how efficient ANI Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.3% Return on Equity means ANI Pharmaceuticals Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ANI Pharmaceuticals Inc:

  • The MRQ is 0.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM1.1%-0.8%
TTM1.1%YOY-3.5%+4.6%
TTM1.1%5Y-1.7%+2.8%
5Y-1.7%10Y0.2%-1.9%

1.2. Operating Efficiency of ANI Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ANI Pharmaceuticals Inc is operating .

  • Measures how much profit ANI Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 6.6% means the company generated $0.07  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ANI Pharmaceuticals Inc:

  • The MRQ is 6.6%. The company is operating less efficient.
  • The TTM is 9.8%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.6%TTM9.8%-3.1%
TTM9.8%YOY-9.7%+19.5%
TTM9.8%5Y-3.0%+12.8%
5Y-3.0%10Y10.1%-13.1%
1.2.2. Operating Ratio

Measures how efficient ANI Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are $0.93 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of ANI Pharmaceuticals Inc:

  • The MRQ is 0.934. The company is less efficient in keeping operating costs low.
  • The TTM is 0.897. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.934TTM0.897+0.036
TTM0.897YOY1.099-0.202
TTM0.8975Y1.025-0.128
5Y1.02510Y0.892+0.134

1.3. Liquidity of ANI Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if ANI Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.57 means the company has $3.57 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of ANI Pharmaceuticals Inc:

  • The MRQ is 3.572. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.477. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.572TTM3.477+0.094
TTM3.477YOY3.597-0.120
TTM3.4775Y2.648+0.830
5Y2.64810Y5.887-3.239
1.3.2. Quick Ratio

Measures if ANI Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.63 means the company can pay off $2.63 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ANI Pharmaceuticals Inc:

  • The MRQ is 2.634. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.513. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.634TTM2.513+0.121
TTM2.513YOY2.350+0.163
TTM2.5135Y1.787+0.726
5Y1.78710Y4.779-2.992

1.4. Solvency of ANI Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ANI Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ANI Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.52 means that ANI Pharmaceuticals Inc assets are financed with 52.2% credit (debt) and the remaining percentage (100% - 52.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ANI Pharmaceuticals Inc:

  • The MRQ is 0.522. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.515. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.522TTM0.515+0.006
TTM0.515YOY0.546-0.031
TTM0.5155Y0.550-0.035
5Y0.55010Y0.491+0.059
1.4.2. Debt to Equity Ratio

Measures if ANI Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 109.0% means that company has $1.09 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ANI Pharmaceuticals Inc:

  • The MRQ is 1.090. The company is able to pay all its debts with equity. +1
  • The TTM is 1.070. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.090TTM1.070+0.020
TTM1.070YOY1.206-0.136
TTM1.0705Y1.233-0.163
5Y1.23310Y1.051+0.182

2. Market Valuation of ANI Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings ANI Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare ANI Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 250.40 means the investor is paying $250.40 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ANI Pharmaceuticals Inc:

  • The EOD is 294.950. Based on the earnings, the company is expensive. -2
  • The MRQ is 250.401. Based on the earnings, the company is expensive. -2
  • The TTM is 132.770. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD294.950MRQ250.401+44.549
MRQ250.401TTM132.770+117.631
TTM132.770YOY-20.357+153.127
TTM132.7705Y188.383-55.613
5Y188.38310Y125.213+63.170
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ANI Pharmaceuticals Inc:

  • The EOD is 8.525. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.237. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 12.412. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD8.525MRQ7.237+1.288
MRQ7.237TTM12.412-5.175
TTM12.412YOY-18.585+30.997
TTM12.4125Y24.745-12.333
5Y24.74510Y-1,714.627+1,739.372
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ANI Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of ANI Pharmaceuticals Inc:

  • The EOD is 3.149. Based on the equity, the company is fair priced.
  • The MRQ is 2.673. Based on the equity, the company is underpriced. +1
  • The TTM is 2.602. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.149MRQ2.673+0.476
MRQ2.673TTM2.602+0.072
TTM2.602YOY2.012+0.590
TTM2.6025Y3.761-1.159
5Y3.76110Y5.291-1.531
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of ANI Pharmaceuticals Inc.

3.1. Institutions holding ANI Pharmaceuticals Inc

Institutions are holding 75.437% of the shares of ANI Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc11.98440.00362524893239230.9565
2023-12-31Vanguard Group Inc6.11810.0016128897215659413.8288
2023-12-31Rubric Capital Management LP5.33981.2871112500027798932.82
2023-12-31Deep Track Capital, LP2.84791.104960000020000050
2023-12-31State Street Corporation2.81190.0016592423369406.6501
2023-12-31Dimensional Fund Advisors, Inc.2.80870.0095591731333595.9743
2023-12-31Global Alpha Capital Management Ltd.2.76452.58145824285690010.8272
2023-12-31William Blair Investment Management, LLC2.32840.0787490557-9502-1.9002
2023-12-31Ranger Investment Management LP2.06291.45343461777691.8201
2023-12-31Geode Capital Management, LLC1.56490.001932968983682.6042
2023-12-31Amvescap Plc.1.22670.0034258446-81289-23.9272
2023-12-31Ameriprise Financial Inc1.1220.0039236394-11019-4.4537
2023-12-31Morgan Stanley - Brokerage Accounts1.10090.0011231943122905.5952
2023-12-31Macquarie Group Ltd1.0920.01472300622300620
2023-12-31Kennedy Capital Management Inc1.08670.2757228954108824.9901
2023-12-31JPMorgan Chase & Co1.06330.0012224023130210138.7974
2023-12-31Thompson, Siegel & Walmsley LLC1.01060.1899212911-15796-6.9067
2023-12-31Loomis, Sayles & Company LP0.85640.0152180429152009.1994
2023-12-31Northern Trust Corp0.79320.0017167102-3083-1.8116
2023-12-31Nuveen Asset Management, LLC0.75610.0028159294-62137-28.0616
Total 50.73947.032910689868+1017660+9.5%

3.2. Funds holding ANI Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28iShares Core S&P Small-Cap ETF4.87870.0881102356514560.1425
2024-02-29Vanguard Total Stock Mkt Idx Inv2.41650.002250698300
2024-03-28iShares Russell 2000 ETF1.72460.038236183137821.0563
2023-11-30MEDICAL BioHealth EUR Acc1.221.9777255965-71862-21.9207
2024-03-31Ranger Small Cap1.15931.2623243233-38119-13.5485
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.10520.0154231880-1172-0.5029
2024-02-29William Blair Small Cap Value I0.92410.979819387000
2024-02-29CC&L Global Alpha - Series A0.91421.1787191800-31800-14.2218
2024-03-28Invesco Pharmaceuticals ETF0.83424.206317502300
2023-12-31Ranger Micro Cap0.73023.63051531961531960
2024-03-28iShares S&P Small-Cap 600 Growth ETF0.70240.172314736500
2024-01-31Fidelity Small Cap Index0.70040.033114695220281.3994
2023-12-31Delaware Ivy Small Cap Growth C0.70010.58871468901468900
2024-03-28SPDR® Portfolio S&P 600 Sm Cap ETF0.64410.08881351401350.1
2024-01-31TIAA-CREF Quant Small-Cap Equity Instl0.58130.22731219502086020.6351
2024-02-29Vanguard Tax-Managed Small Cap Adm0.56140.089711777900
2023-12-31Kennedy Small Cap Value0.50210.8576105347-22098-17.3392
2023-12-31Vanguard Explorer Inv0.49160.02661031314103566.0832
2024-03-28iShares Russell 2000 Growth ETF0.46810.058398202-114-0.116
2024-02-29DFA US Targeted Value I0.45930.05059637100
Total 21.717815.57214556473+204217+4.5%

3.3. Insider Transactions

Insiders are holding 11.074% of the shares of ANI Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-01Chad GassertSELL2000067.25
2024-03-11Stephen P CareySELL778765.55
2024-03-08Nikhil LalwaniSELL1629267.13
2024-03-07James G MarkenSELL2433866.37
2024-03-07Muthusamy ShanmugamSELL1508566.35
2024-03-06Nikhil LalwaniSELL2896565.52
2024-03-05Muthusamy ShanmugamSELL1009365.35
2024-02-13Meredith CookSELL25056.04
2024-01-22Muthusamy ShanmugamSELL569255.95
2024-01-18Muthusamy ShanmugamSELL978455.3
2024-01-16Muthusamy ShanmugamSELL500055.63
2024-01-12Meredith CookSELL25056.43
2023-12-18Muthusamy ShanmugamSELL1302652.44
2023-12-15Muthusamy ShanmugamSELL1197452.44
2023-12-11Meredith CookSELL25049.21
2023-11-16Muthusamy ShanmugamSELL644851.66
2023-11-15Krista DavisSELL262253.81
2023-11-14Muthusamy ShanmugamSELL2209553.17
2023-10-18Muthusamy ShanmugamSELL624257.78
2023-10-16Muthusamy ShanmugamSELL1306358.31

4. Summary

4.1. Key Performance Indicators

The key performance indicators of ANI Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.0471.123-193%-0.241-77%0.561-287%0.467-324%
Book Value Per Share--20.62619.797+4%16.185+27%13.303+55%10.413+98%
Current Ratio--3.5723.477+3%3.597-1%2.648+35%5.887-39%
Debt To Asset Ratio--0.5220.515+1%0.546-5%0.550-5%0.491+6%
Debt To Equity Ratio--1.0901.070+2%1.206-10%1.233-12%1.051+4%
Dividend Per Share--0.0190.0190%0.0190%0.010+102%0.005+305%
Eps--0.0550.214-74%-0.590+1172%-0.216+493%-0.034+161%
Free Cash Flow Per Share--1.9051.197+59%-0.568+130%-0.006+100%-0.197+110%
Free Cash Flow To Equity Per Share--1.3372.001-33%-0.629+147%0.606+121%0.367+265%
Gross Profit Margin--1.0001.0000%1.0000%1.009-1%1.0050%
Intrinsic Value_10Y_max--70.227--------
Intrinsic Value_10Y_min--22.598--------
Intrinsic Value_1Y_max--1.462--------
Intrinsic Value_1Y_min---0.272--------
Intrinsic Value_3Y_max--8.642--------
Intrinsic Value_3Y_min--1.374--------
Intrinsic Value_5Y_max--20.944--------
Intrinsic Value_5Y_min--5.410--------
Market Cap1362670485.000+15%1156853742.0001084419256.250+7%682646511.250+69%948949459.150+22%1007361236.888+15%
Net Profit Margin--0.0090.038-77%-0.165+1986%-0.081+1027%0.024-63%
Operating Margin--0.0660.098-32%-0.097+247%-0.030+146%0.101-35%
Operating Ratio--0.9340.897+4%1.099-15%1.025-9%0.892+5%
Pb Ratio3.149+15%2.6732.602+3%2.012+33%3.761-29%5.291-49%
Pe Ratio294.950+15%250.401132.770+89%-20.357+108%188.383+33%125.213+100%
Price Per Share64.950+15%55.14051.688+7%32.538+69%45.231+22%48.015+15%
Price To Free Cash Flow Ratio8.525+15%7.23712.412-42%-18.585+357%24.745-71%-1714.627+23791%
Price To Total Gains Ratio-63.215-18%-53.667158.844-134%1433.543-104%129.682-141%329.180-116%
Quick Ratio--2.6342.513+5%2.350+12%1.787+47%4.779-45%
Return On Assets--0.0010.005-76%-0.016+1355%-0.007+674%0.003-54%
Return On Equity--0.0030.011-75%-0.035+1416%-0.017+750%0.002+32%
Total Gains Per Share---1.0271.142-190%-0.221-78%0.571-280%0.472-318%
Usd Book Value--432749000.000415353500.000+4%339566750.000+27%279102850.000+55%218461625.000+98%
Usd Book Value Change Per Share---1.0471.123-193%-0.241-77%0.561-287%0.467-324%
Usd Book Value Per Share--20.62619.797+4%16.185+27%13.303+55%10.413+98%
Usd Dividend Per Share--0.0190.0190%0.0190%0.010+102%0.005+305%
Usd Eps--0.0550.214-74%-0.590+1172%-0.216+493%-0.034+161%
Usd Free Cash Flow--39961000.00025112000.000+59%-11914500.000+130%-124950.000+100%-4140975.000+110%
Usd Free Cash Flow Per Share--1.9051.197+59%-0.568+130%-0.006+100%-0.197+110%
Usd Free Cash Flow To Equity Per Share--1.3372.001-33%-0.629+147%0.606+121%0.367+265%
Usd Market Cap1362670485.000+15%1156853742.0001084419256.250+7%682646511.250+69%948949459.150+22%1007361236.888+15%
Usd Price Per Share64.950+15%55.14051.688+7%32.538+69%45.231+22%48.015+15%
Usd Profit--1155000.0004694750.000-75%-11974000.000+1137%-4408700.000+482%-642475.000+156%
Usd Revenue--131654000.000121704000.000+8%79096250.000+66%71717950.000+84%51842275.000+154%
Usd Total Gains Per Share---1.0271.142-190%-0.221-78%0.571-280%0.472-318%
 EOD+3 -5MRQTTM+13 -22YOY+23 -125Y+28 -810Y+19 -17

4.2. Fundamental Score

Let's check the fundamental score of ANI Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15294.950
Price to Book Ratio (EOD)Between0-13.149
Net Profit Margin (MRQ)Greater than00.009
Operating Margin (MRQ)Greater than00.066
Quick Ratio (MRQ)Greater than12.634
Current Ratio (MRQ)Greater than13.572
Debt to Asset Ratio (MRQ)Less than10.522
Debt to Equity Ratio (MRQ)Less than11.090
Return on Equity (MRQ)Greater than0.150.003
Return on Assets (MRQ)Greater than0.050.001
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of ANI Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.118
Ma 20Greater thanMa 5066.634
Ma 50Greater thanMa 10065.374
Ma 100Greater thanMa 20059.878
OpenGreater thanClose65.050
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets904,422
Total Liabilities471,673
Total Stockholder Equity432,749
 As reported
Total Liabilities 471,673
Total Stockholder Equity+ 432,749
Total Assets = 904,422

Assets

Total Assets904,422
Total Current Assets519,616
Long-term Assets384,806
Total Current Assets
Cash And Cash Equivalents 221,121
Net Receivables 162,079
Inventory 111,196
Other Current Assets 25,220
Total Current Assets  (as reported)519,616
Total Current Assets  (calculated)519,616
+/-0
Long-term Assets
Property Plant Equipment 44,593
Goodwill 28,221
Intangible Assets 209,009
Long-term Assets Other 12,272
Long-term Assets  (as reported)384,806
Long-term Assets  (calculated)294,095
+/- 90,711

Liabilities & Shareholders' Equity

Total Current Liabilities145,477
Long-term Liabilities326,196
Total Stockholder Equity432,749
Total Current Liabilities
Short-term Debt 850
Short Long Term Debt 850
Accounts payable 36,683
Other Current Liabilities 99,780
Total Current Liabilities  (as reported)145,477
Total Current Liabilities  (calculated)138,163
+/- 7,314
Long-term Liabilities
Long term Debt 284,819
Long-term Liabilities Other 16,527
Long-term Liabilities  (as reported)326,196
Long-term Liabilities  (calculated)301,346
+/- 24,850
Total Stockholder Equity
Common Stock2
Retained Earnings -80,132
Accumulated Other Comprehensive Income 8,857
Other Stockholders Equity 479,172
Total Stockholder Equity (as reported)432,749
Total Stockholder Equity (calculated)407,899
+/- 24,850
Other
Capital Stock24,852
Cash and Short Term Investments 221,121
Common Stock Shares Outstanding 19,219
Current Deferred Revenue8,164
Liabilities and Stockholders Equity 904,422
Net Debt 94,207
Net Invested Capital 718,418
Net Working Capital 374,339
Property Plant and Equipment Gross 77,528
Short Long Term Debt Total 315,328



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-06-30
> Total Assets 
0
5,291
3,831
3,725
3,067
5,637
5,210
6,491
4,979
4,979
2,142
5,781
5,880
3,934
2,740
10,897
9,565
8,671
23,349
21,070
17,827
15,206
12,493
10,784
9,575
7,483
4,903
10,735
22,371
19,048
35,155
33,415
31,241
28,717
24,330
19,822
17,679
13,216
9,529
15,959
36,437
47,316
51,783
40,763
44,767
56,805
42,764
74,891
62,380
54,575
47,295
43,212
38,769
35,356
41,658
43,286
44,500
96,652
95,423
107,637
263,709
265,985
270,121
283,276
285,265
291,588
307,999
319,379
322,864
357,138
359,219
370,469
412,138
418,019
424,177
439,443
430,604
434,390
446,906
456,775
456,789
482,232
465,391
462,581
461,190
463,843
480,159
470,454
771,598
744,846
751,334
739,110
760,087
765,224
859,341
889,914
904,422
904,422889,914859,341765,224760,087739,110751,334744,846771,598470,454480,159463,843461,190462,581465,391482,232456,789456,775446,906434,390430,604439,443424,177418,019412,138370,469359,219357,138322,864319,379307,999291,588285,265283,276270,121265,985263,709107,63795,42396,65244,50043,28641,65835,35638,76943,21247,29554,57562,38074,89142,76456,80544,76740,76351,78347,31636,43715,9599,52913,21617,67919,82224,33028,71731,24133,41535,15519,04822,37110,7354,9037,4839,57510,78412,49315,20617,82721,07023,3498,6719,56510,8972,7403,9345,8805,7812,1424,9794,9796,4915,2105,6373,0673,7253,8315,2910
   > Total Current Assets 
0
4,858
3,405
3,321
2,676
5,268
4,845
6,094
4,594
4,594
1,777
5,430
5,548
3,625
2,455
10,631
9,318
8,416
23,088
20,825
17,578
14,954
12,251
10,565
9,347
7,283
4,713
10,540
22,208
18,919
35,071
33,346
31,007
27,945
23,454
18,552
16,087
11,652
7,733
14,219
31,410
42,452
47,318
36,677
40,625
52,487
38,139
70,544
58,026
50,191
42,930
38,583
35,173
31,927
24,119
26,095
27,716
67,936
67,160
57,565
203,478
202,993
208,948
197,522
192,583
116,552
79,824
95,475
103,007
106,981
112,856
125,582
131,605
143,394
152,367
156,793
152,877
151,832
168,912
182,386
187,695
158,662
156,544
165,819
170,321
182,798
191,799
191,384
321,775
301,399
322,399
309,377
344,261
364,753
459,311
497,220
519,616
519,616497,220459,311364,753344,261309,377322,399301,399321,775191,384191,799182,798170,321165,819156,544158,662187,695182,386168,912151,832152,877156,793152,367143,394131,605125,582112,856106,981103,00795,47579,824116,552192,583197,522208,948202,993203,47857,56567,16067,93627,71626,09524,11931,92735,17338,58342,93050,19158,02670,54438,13952,48740,62536,67747,31842,45231,41014,2197,73311,65216,08718,55223,45427,94531,00733,34635,07118,91922,20810,5404,7137,2839,34710,56512,25114,95417,57820,82523,0888,4169,31810,6312,4553,6255,5485,4301,7774,5944,5946,0944,8455,2682,6763,3213,4054,8580
       Cash And Cash Equivalents 
0
4,812
3,366
3,235
2,612
5,222
4,782
5,979
4,502
4,502
1,704
5,258
4,884
3,412
2,335
10,396
9,134
8,262
22,973
20,576
1,170
56
380
254
311
70
134
366
7,654
11,291
27,382
25,403
15,649
13,106
10,326
5,701
11,761
10,162
5,986
13,169
29,858
41,163
46,382
35,526
38,155
51,349
37,126
69,600
57,225
49,474
42,417
38,049
34,794
29,389
12,595
10,930
11,105
51,373
52,961
35,050
169,037
165,563
166,731
150,913
154,684
77,747
15,014
16,155
27,365
10,826
8,369
18,031
31,144
51,970
54,994
44,136
43,008
38,233
40,589
59,673
62,332
20,414
27,702
17,900
7,864
25,073
24,261
15,254
100,300
76,911
63,385
56,281
48,228
67,757
161,707
193,078
221,121
221,121193,078161,70767,75748,22856,28163,38576,911100,30015,25424,26125,0737,86417,90027,70220,41462,33259,67340,58938,23343,00844,13654,99451,97031,14418,0318,36910,82627,36516,15515,01477,747154,684150,913166,731165,563169,03735,05052,96151,37311,10510,93012,59529,38934,79438,04942,41749,47457,22569,60037,12651,34938,15535,52646,38241,16329,85813,1695,98610,16211,7615,70110,32613,10615,64925,40327,38211,2917,65436613470311254380561,17020,57622,9738,2629,13410,3962,3353,4124,8845,2581,7044,5024,5025,9794,7825,2222,6123,2353,3664,8120
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,099
14,693
11,693
10,045
8,791
6,985
4,372
9,904
3,796
3,857
3,904
3,953
15,006
14,472
12,430
11,770
3,026
3,026
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,260
2,260
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000002,2602,26000000000000000003,0263,02611,77012,43014,47215,0063,9533,9043,8573,7969,9044,3726,9858,79110,04511,69314,69316,09900000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,511
3,515
3,577
3,600
15
30
21
83
230
357
117
38
65
133
53
0
0
0
0
0
0
0
0
0
0
0
6,428
9,515
12,513
10,907
7,794
14,570
17,297
17,371
18,880
21,645
21,932
22,481
35,562
47,477
45,895
46,697
55,513
62,174
58,788
54,801
56,115
67,647
64,842
67,410
76,274
70,700
72,129
82,379
73,162
83,745
95,793
91,876
92,648
106,714
128,526
131,625
150,410
140,433
165,438
174,713
172,925
178,842
162,079
162,079178,842172,925174,713165,438140,433150,410131,625128,526106,71492,64891,87695,79383,74573,16282,37972,12970,70076,27467,41064,84267,64756,11554,80158,78862,17455,51346,69745,89547,47735,56222,48121,93221,64518,88017,37117,29714,5707,79410,90712,5139,5156,42800000000000531336538117357230832130153,6003,5773,51510,5110000000000000000000000000000
       Other Current Assets 
0
45
39
86
64
46
63
115
0
92
72
172
520
65
120
235
183
154
115
249
310
205
178
266
245
228
208
270
248
257
208
391
337
336
677
998
1,070
1,133
1,630
1,011
1,487
1,157
883
1,151
2,470
1,138
1,013
944
801
717
513
534
379
278
252
581
27,716
566
493
599
1,983
1,546
1,615
1,985
1,453
1,252
4,046
2,653
3,564
3,565
2,676
4,847
2,784
2,267
1,768
5,004
4,524
4,157
3,311
5,025
3,995
2,967
3,117
3,358
5,861
5,922
4,881
4,702
7,589
9,708
16,059
16,770
8,387
6,874
8,248
10,690
25,220
25,22010,6908,2486,8748,38716,77016,0599,7087,5894,7024,8815,9225,8613,3583,1172,9673,9955,0253,3114,1574,5245,0041,7682,2672,7844,8472,6763,5653,5642,6534,0461,2521,4531,9851,6151,5461,98359949356627,7165812522783795345137178019441,0131,1382,4701,1518831,1571,4871,0111,6301,1331,07099867733633739120825724827020822824526617820531024911515418323512065520172729201156346648639450
   > Long-term Assets 
0
434
425
404
391
369
365
397
0
385
365
351
332
308
285
266
248
255
261
245
249
252
242
219
228
201
190
195
162
129
84
69
234
773
876
1,270
1,592
1,564
1,796
1,740
5,027
4,864
4,465
4,086
4,142
4,319
4,625
4,347
4,353
4,384
4,365
4,629
3,596
3,430
17,539
17,191
16,784
28,716
28,263
50,072
60,231
62,992
61,173
85,754
92,682
175,036
228,175
223,904
219,857
250,157
246,363
244,887
280,533
274,625
271,810
282,650
277,727
282,558
277,994
274,389
269,094
323,570
308,847
296,762
290,869
281,045
288,360
279,070
449,823
443,447
428,935
429,733
415,826
400,471
400,030
392,694
384,806
384,806392,694400,030400,471415,826429,733428,935443,447449,823279,070288,360281,045290,869296,762308,847323,570269,094274,389277,994282,558277,727282,650271,810274,625280,533244,887246,363250,157219,857223,904228,175175,03692,68285,75461,17362,99260,23150,07228,26328,71616,78417,19117,5393,4303,5964,6294,3654,3844,3534,3474,6254,3194,1424,0864,4654,8645,0271,7401,7961,5641,5921,270876773234698412916219519020122821924225224924526125524826628530833235136538503973653693914044254340
       Property Plant Equipment 
0
434
425
404
391
369
365
397
385
385
365
351
332
308
285
266
248
255
261
245
249
252
242
219
216
189
165
170
137
104
59
44
55
60
162
529
815
786
753
720
748
710
684
647
636
813
1,133
855
861
884
862
1,185
166
0
4,741
4,640
4,537
4,518
4,625
5,046
5,223
5,281
5,249
5,833
7,131
8,415
8,911
9,716
10,998
12,897
14,966
17,387
20,403
21,882
22,842
37,418
38,090
38,425
38,953
39,754
40,551
40,353
39,937
40,444
41,269
40,767
40,334
39,526
52,671
52,713
43,771
42,830
43,246
43,275
44,371
44,189
44,593
44,59344,18944,37143,27543,24642,83043,77152,71352,67139,52640,33440,76741,26940,44439,93740,35340,55139,75438,95338,42538,09037,41822,84221,88220,40317,38714,96612,89710,9989,7168,9118,4157,1315,8335,2495,2815,2235,0464,6254,5184,5374,6404,74101661,1858628848618551,133813636647684710748720753786815529162605544591041371701651892162192422522492452612552482662853083323513653853853973653693914044254340
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
1,838
4,180
3,580
3,580
3,580
3,580
3,580
3,580
3,580
3,580
3,580
3,580
3,580
3,580
27,888
28,188
28,221
28,221
28,221
28,221
28,221
28,221
28,221
28,22128,22128,22128,22128,22128,22128,22128,18827,8883,5803,5803,5803,5803,5803,5803,5803,5803,5803,5803,5803,5804,1801,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,838000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,406
3,406
3,406
3,414
3,414
3,414
3,414
3,414
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000700300000000000000000000003,4143,4143,4143,4143,4143,4063,4063,4060000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
85
0
10,960
10,712
10,409
22,360
21,800
43,188
42,067
45,408
44,174
68,291
66,397
147,386
194,674
188,949
175,792
203,459
196,624
189,829
229,790
221,917
217,484
209,544
201,604
205,100
196,697
188,372
180,388
215,619
205,745
198,620
188,511
178,859
180,199
170,141
294,122
281,573
269,593
264,237
251,635
238,791
230,299
219,828
209,009
209,009219,828230,299238,791251,635264,237269,593281,573294,122170,141180,199178,859188,511198,620205,745215,619180,388188,372196,697205,100201,604209,544217,484221,917229,790189,829196,624203,459175,792188,949194,674147,38666,39768,29144,17445,40842,06743,18821,80022,36010,40910,71210,9600850000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
302
0
12,798
12,550
12,247
24,198
23,638
45,026
55,008
57,711
55,924
79,921
85,551
166,621
219,264
214,188
208,859
237,260
231,397
227,500
260,130
28,988
29,346
30,808
34,453
35,453
38,764
42,683
44,575
64,018
59,585
54,118
57,509
57,839
64,247
65,823
75,142
80,573
83,750
85,045
92,724
90,184
87,939
0
0
0087,93990,18492,72485,04583,75080,57375,14265,82364,24757,83957,50954,11859,58564,01844,57542,68338,76435,45334,45330,80829,34628,988260,130227,500231,397237,260208,859214,188219,264166,62185,55179,92155,92457,71155,00845,02623,63824,19812,24712,55012,79803020000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,796
7,369
7,027
7,118
17,316
17,397
17,751
18,400
26,227
26,962
27,933
30,829
22,667
23,163
23,590
25,082
27,964
28,542
31,957
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000031,95728,54227,96425,08223,59023,16322,66730,82927,93326,96226,22718,40017,75117,39717,3167,1187,0277,3697,796000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
286
247
697
941
795
941
1,029
928
928
736
693
1,256
555
721
700
881
1,147
1,176
1,336
1,907
1,811
1,551
1,607
2,756
2,790
2,325
1,706
4,300
2,431
2,611
2,235
1,516
2,927
3,621
4,570
3,853
3,105
3,717
4,777
20,607
24,310
25,158
25,459
25,620
30,669
31,233
30,742
24,564
16,579
16,374
10,922
10,594
9,326
6,163
6,597
3,538
4,560
3,828
8,145
123,924
121,245
120,621
127,383
125,183
131,410
144,223
150,549
153,216
184,926
182,673
187,668
237,382
238,375
239,067
246,978
233,341
234,678
239,250
243,645
243,998
281,061
274,047
267,481
265,490
260,131
288,242
279,051
412,858
398,752
414,376
402,435
421,547
425,742
424,869
435,203
471,673
471,673435,203424,869425,742421,547402,435414,376398,752412,858279,051288,242260,131265,490267,481274,047281,061243,998243,645239,250234,678233,341246,978239,067238,375237,382187,668182,673184,926153,216150,549144,223131,410125,183127,383120,621121,245123,9248,1453,8284,5603,5386,5976,1639,32610,59410,92216,37416,57924,56430,74231,23330,66925,62025,45925,15824,31020,6074,7773,7173,1053,8534,5703,6212,9271,5162,2352,6112,4314,3001,7062,3252,7902,7561,6071,5511,8111,9071,3361,1761,1478817007215551,2566937369289281,0299417959416972472860
   > Total Current Liabilities 
0
286
247
697
941
795
941
1,029
928
928
736
693
1,256
555
721
700
881
1,147
1,176
1,336
1,907
1,811
1,551
1,505
2,666
2,735
2,304
1,663
4,300
2,431
2,611
2,235
1,516
2,927
3,621
4,570
3,853
3,105
3,717
4,777
3,930
6,225
6,690
7,095
8,183
12,633
11,481
11,500
7,228
6,085
16,374
10,922
10,594
9,326
6,163
6,597
3,538
4,560
3,828
8,145
13,233
9,073
6,949
12,190
11,756
16,211
24,730
30,491
31,948
32,425
28,292
36,384
39,228
39,650
39,678
46,902
165,549
165,068
166,794
170,707
61,676
79,356
79,088
75,900
78,565
82,768
89,454
84,872
87,537
79,532
96,312
81,627
99,439
125,825
122,865
134,352
145,477
145,477134,352122,865125,82599,43981,62796,31279,53287,53784,87289,45482,76878,56575,90079,08879,35661,676170,707166,794165,068165,54946,90239,67839,65039,22836,38428,29232,42531,94830,49124,73016,21111,75612,1906,9499,07313,2338,1453,8284,5603,5386,5976,1639,32610,59410,92216,3746,0857,22811,50011,48112,6338,1837,0956,6906,2253,9304,7773,7173,1053,8534,5703,6212,9271,5162,2352,6112,4314,3001,6632,3042,7352,6661,5051,5511,8111,9071,3361,1761,1478817007215551,2566937369289281,0299417959416972472860
       Short-term Debt 
0
0
0
500
500
500
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
640
0
0
0
434
465
796
776
795
614
0
0
0
0
0
0
0
0
0
0
1,111
1,150
1,187
1,234
0
0
10,478
7,593
7,884
8,169
4,115
4,332
1,326
1,013
1,133
0
106,540
0
0
0
113,427
0
0
0
120,643
152,501
154,381
151,284
3,353
3,805
5,217
5,692
115,719
117,393
120,007
121,740
9,941
11,872
12,329
12,785
13,243
14,438
15,182
15,927
850
850
850
850
850
850
850
850
850
85085085085085085085085085015,92715,18214,43813,24312,78512,32911,8729,941121,740120,007117,393115,7195,6925,2173,8053,353151,284154,381152,501120,643000113,427000106,54001,1331,0131,3264,3324,1158,1697,8847,59310,478001,2341,1871,1501,111000000000061479577679646543400064000000000000000000500500500500000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
106,540
0
0
0
113,427
0
0
0
120,643
152,501
154,381
151,284
3,353
3,805
5,217
5,692
115,719
117,393
120,007
121,740
9,941
11,872
12,329
12,785
13,243
14,438
15,182
15,927
850
850
850
850
850
850
850
850
850
85085085085085085085085085015,92715,18214,43813,24312,78512,32911,8729,941121,740120,007117,393115,7195,6925,2173,8053,353151,284154,381152,501120,643000113,427000106,540000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
101
111
68
45
93
194
100
0
91
287
529
471
248
479
272
239
376
608
856
1,169
1,053
782
518
1,140
1,380
670
318
622
644
889
559
711
2,301
2,620
3,420
3,182
2,429
2,550
3,529
2,440
4,003
4,719
4,523
4,864
8,504
6,349
6,042
3,151
3,282
3,836
2,005
1,129
164
1,635
2,087
1,429
2,660
1,731
3,059
2,654
2,288
1,325
2,633
2,066
3,040
4,961
4,730
3,389
4,785
3,153
5,821
3,630
4,886
7,949
7,257
8,884
10,519
9,809
10,953
14,606
12,485
14,209
13,460
11,261
13,769
12,977
11,513
22,967
22,059
27,641
18,992
29,305
32,687
28,505
34,077
36,683
36,68334,07728,50532,68729,30518,99227,64122,05922,96711,51312,97713,76911,26113,46014,20912,48514,60610,9539,80910,5198,8847,2577,9494,8863,6305,8213,1534,7853,3894,7304,9613,0402,0662,6331,3252,2882,6543,0591,7312,6601,4292,0871,6351641,1292,0053,8363,2823,1516,0426,3498,5044,8644,5234,7194,0032,4403,5292,5502,4293,1823,4202,6202,3017115598896446223186701,3801,1405187821,0531,1698566083762392724792484715292879101001949345681111010
       Other Current Liabilities 
0
185
136
129
397
201
247
929
0
837
448
164
785
307
242
428
642
771
568
480
738
758
768
850
750
1,218
1,498
1,242
3,176
1,288
899
881
1
7
1,001
1,146
671
675
1,166
1,248
1,490
2,222
1,971
2,572
2,208
2,979
5,133
4,224
4,077
2,803
2,060
1,324
1,581
992
366
132
736
849
951
5,066
10,579
6,785
5,624
9,557
9,690
13,171
19,769
25,761
28,559
27,640
25,139
30,563
8,274
9,020
9,764
33,218
40,235
36,532
36,420
37,518
36,678
54,681
52,425
49,543
53,981
54,499
61,233
57,370
63,633
56,507
67,821
61,785
69,284
92,288
89,422
23,939
99,780
99,78023,93989,42292,28869,28461,78567,82156,50763,63357,37061,23354,49953,98149,54352,42554,68136,67837,51836,42036,53240,23533,2189,7649,0208,27430,56325,13927,64028,55925,76119,76913,1719,6909,5575,6246,78510,5795,0669518497361323669921,5811,3242,0602,8034,0774,2245,1332,9792,2082,5721,9712,2221,4901,2481,1666756711,1461,001718818991,2883,1761,2421,4981,21875085076875873848056877164242824230778516444883709292472013971291361850
   > Long-term Liabilities 
0
0
0
92,136
0
0
0
27,401
0
24,444
61,277
33,487
0
0
0
0
0
0
0
0
0
0
0
102
90
56
22
43
0
0
0
0
0
0
0
0
0
0
0
0
16,676
18,085
18,467
18,364
17,436
18,037
19,752
19,242
17,337
10,494
12,538
8,917
0
0
0
0
0
0
0
0
110,691
112,172
113,672
115,193
113,427
115,199
119,493
120,058
121,268
152,501
154,381
151,284
198,154
198,725
199,389
200,076
67,792
69,610
72,456
72,938
182,322
201,705
194,959
191,581
186,925
177,363
198,788
194,179
325,321
319,220
318,064
320,808
322,108
299,917
302,004
300,851
326,196
326,196300,851302,004299,917322,108320,808318,064319,220325,321194,179198,788177,363186,925191,581194,959201,705182,32272,93872,45669,61067,792200,076199,389198,725198,154151,284154,381152,501121,268120,058119,493115,199113,427115,193113,672112,172110,691000000008,91712,53810,49417,33719,24219,75218,03717,43618,36418,46718,08516,676000000000000432256901020000000000033,48761,27724,444027,40100092,136000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,752
19,242
17,337
10,494
0
0
0
0
0
0
0
0
0
0
0
0
113,672
115,193
0
0
116,993
118,808
120,643
152,501
154,381
151,284
128,208
130,156
199,389
200,076
67,296
66,501
65,688
64,873
175,808
188,094
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000188,094175,80864,87365,68866,50167,296200,076199,389130,156128,208151,284154,381152,501120,643118,808116,99300115,193113,67200000000000010,49417,33719,24219,7520000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,796
7,369
7,027
7,118
17,316
17,397
17,751
18,400
26,227
26,962
27,933
30,829
22,667
23,163
23,590
25,082
27,964
28,542
31,957
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000031,95728,54227,96425,08223,59023,16322,66730,82927,93326,96226,22718,40017,75117,39717,3167,1187,0277,3697,796000000000000000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,850
24,850
24,850
24,850
24,850
24,850
24,850
0
0
0024,85024,85024,85024,85024,85024,85024,8500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
625
0
0
0
625
0
2,500
1,250
625
0
0
0
0
0
0
0
496
0
6,768
2
7
0
1
200
201
6
0
0
31,016
32,053
30,970
33,445
35,058
13,258
12,029
0
0
0012,02913,25835,05833,44530,97032,05331,01600620120010726,768049600000006251,2502,5000625000625000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
829
823
749
700
1,468
1,300
1,300
1,200
800
700
600
600
500
400
400
300
800
800
700
700
600
0
500
0
0
0050006007007008008003004004005006006007008001,2001,3001,3001,468700749823829000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
5,005
3,583
3,028
2,126
4,843
4,269
5,462
0
4,051
1,406
5,088
4,624
3,379
2,019
10,197
8,684
7,525
22,173
19,734
15,921
13,395
10,942
9,177
6,819
4,693
2,578
9,029
18,071
16,618
32,545
31,181
29,725
25,791
20,708
15,252
13,826
10,111
5,813
11,182
15,830
23,006
26,626
15,304
19,147
26,136
11,531
44,149
37,815
37,996
30,921
32,290
28,176
26,031
35,495
36,689
40,962
92,092
91,595
99,492
139,785
144,740
149,500
155,893
160,082
160,178
163,776
168,830
169,648
172,212
176,546
182,801
174,756
179,644
185,110
192,465
197,263
199,712
207,656
213,130
212,791
201,171
191,344
195,100
195,700
203,712
191,917
191,403
358,740
346,094
336,958
336,675
338,540
339,482
434,472
454,711
432,749
432,749454,711434,472339,482338,540336,675336,958346,094358,740191,403191,917203,712195,700195,100191,344201,171212,791213,130207,656199,712197,263192,465185,110179,644174,756182,801176,546172,212169,648168,830163,776160,178160,082155,893149,500144,740139,78599,49291,59592,09240,96236,68935,49526,03128,17632,29030,92137,99637,81544,14911,53126,13619,14715,30426,62623,00615,83011,1825,81310,11113,82615,25220,70825,79129,72531,18132,54516,61818,0719,0292,5784,6936,8199,17710,94213,39515,92119,73422,1737,5258,68410,1972,0193,3794,6245,0881,4064,05105,4624,2694,8432,1263,0283,5835,0050
   Common Stock
0
17,663
17,676
17,741
17,783
17,783
21,458
22,301
0
22,303
22,256
26,738
26,685
26,685
26,942
36,559
36,705
37,991
55,214
55,644
56,456
56,613
56,654
56,654
56,654
57,668
57,719
64,916
64,968
65,332
83,659
83,988
84,207
84,501
84,864
85,565
85,733
86,068
86,391
98,130
135,264
152,980
167,394
167,662
184,777
209,017
209,387
254,739
255,054
265,500
265,769
273,259
273,132
273,278
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2221111111111111111111111111111111111111111273,278273,132273,259265,769265,500255,054254,739209,387209,017184,777167,662167,394152,980135,26498,13086,39186,06885,73385,56584,86484,50184,20783,98883,65965,33264,96864,91657,71957,66856,65456,65456,65456,61356,45655,64455,21437,99136,70536,55926,94226,68526,68526,73822,25622,303022,30121,45817,78317,78317,74117,67617,6630
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-197,857
-210,590
-217,239
-227,504
-234,848
-240,970
-244,957
-247,248
-53,096
-51,904
-48,472
-45,113
-47,476
-40,730
-19,725
-15,356
-11,785
-7,226
-4,350
-5,504
-4,379
-1,836
-2,916
-1,778
903
5,623
-4,006
-1,756
1,021
6,058
11,488
11,939
18,524
22,419
17,584
10,565
-1,771
-1,337
-4,972
-4,886
-18,992
-23,439
-47,765
-68,300
-83,630
-92,636
-97,286
-96,252
-90,414
0
0
00-90,414-96,252-97,286-92,636-83,630-68,300-47,765-23,439-18,992-4,886-4,972-1,337-1,77110,56517,58422,41918,52411,93911,4886,0581,021-1,756-4,0065,623903-1,778-2,916-1,836-4,379-5,504-4,350-7,226-11,785-15,356-19,725-40,730-47,476-45,113-48,472-51,904-53,096-247,248-244,957-240,970-234,848-227,504-217,239-210,590-197,8570000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-208
-232
-257
-18
3,389
-282
-282
-375
-375
-375
-375
-467
-467
-467
-467
-560
-560
-560
-560
-662
-410
-322
-662
-146
-59
-763
-763
-769
-769
-769
-769
-237
-602
-237
428
-210
-210
0
0
-347
-347
0
-15,303,788
-446
-26,136
-11,531
-44,149
-426
-37,996
0
0
-392
0
-2,929
-3,063
-3,197
-3,334
-3,480
-3,633
-3,794
-3,962
-4,143
-4,257
-4,450
-4,667
-4,894
-5,135
-5,387
-5,704
-5,970
-6,274
-6,589
-6,658
216
533
-379
-2,199
-5,013
-6,037
-4,871
-11,689
-14,049
-13,110
-11,437
-5,032
-5,433
-4,235
-3,055
2,712
5,430
10,039
12,168
11,131
13,726
14,076
8,857
8,85714,07613,72611,13112,16810,0395,4302,712-3,055-4,235-5,433-5,032-11,437-13,110-14,049-11,689-4,871-6,037-5,013-2,199-379533216-6,658-6,589-6,274-5,970-5,704-5,387-5,135-4,894-4,667-4,450-4,257-4,143-3,962-3,794-3,633-3,480-3,334-3,197-3,063-2,9290-39200-37,996-426-44,149-11,531-26,136-446-15,303,7880-347-34700-210-210428-237-602-237-769-769-769-769-763-763-59-146-662-322-410-662-560-560-560-560-467-467-467-467-375-375-375-375-282-2823,389-18-257-232-2080
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89,022
89,025
89,501
137,272
139,070
140,221
159,509
160,095
161,397
163,118
164,431
165,681
168,154
170,665
172,563
173,989
175,901
177,436
179,020
181,649
184,531
186,532
186,812
189,971
194,867
197,470
200,800
203,505
209,409
211,792
214,354
216,223
219,403
222,211
387,844
391,084
395,043
399,396
403,901
408,395
495,488
0
0
00495,488408,395403,901399,396395,043391,084387,844222,211219,403216,223214,354211,792209,409203,505200,800197,470194,867189,971186,812186,532184,531181,649179,020177,436175,901173,989172,563170,665168,154165,681164,431163,118161,397160,095159,509140,221139,070137,27289,50189,02589,022000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000-1,211-723-723-7230-659-659-659-250-259-259-2590000000-1130000-68-68-433-433000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
208
232
257
264
3,671
282
282
0
375
375
375
467
467
467
467
560
560
560
560
662
0
0
662
0
0
58,483
763
769
769
769
769
237
0
237
0
210
0
0
0
347
0
0
15,303,788
446
26,136
11,531
44,149
426
37,996
0
0
391
0
91,518
91,655
92,630
140,538
142,550
143,854
163,303
164,057
165,427
167,375
168,881
170,348
173,048
175,800
177,950
179,693
181,612
183,451
185,350
188,057
183,872
185,873
186,153
189,971
194,144
196,747
200,077
202,294
207,163
209,546
212,108
213,629
216,341
219,076
384,709
386,831
390,307
394,421
398,807
399,752
486,308
496,663
479,172
479,172496,663486,308399,752398,807394,421390,307386,831384,709219,076216,341213,629212,108209,546207,163202,294200,077196,747194,144189,971186,153185,873183,872188,057185,350183,451181,612179,693177,950175,800173,048170,348168,881167,375165,427164,057163,303143,854142,550140,53892,63091,65591,51803910037,99642644,14911,53126,13644615,303,788003470002100237023776976976976976358,483006620066256056056056046746746746737537537502822823,6712642572322080



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue486,816
Cost of Revenue-241,304
Gross Profit245,512245,512
 
Operating Income (+$)
Gross Profit245,512
Operating Expense-195,983
Operating Income49,52949,529
 
Operating Expense (+$)
Research Development34,286
Selling General Administrative150,423
Selling And Marketing Expenses0
Operating Expense195,983184,709
 
Net Interest Income (+$)
Interest Income0
Interest Expense-27,523
Other Finance Cost-1,177
Net Interest Income-28,700
 
Pretax Income (+$)
Operating Income49,529
Net Interest Income-28,700
Other Non-Operating Income Expenses0
Income Before Tax (EBT)19,87279,186
EBIT - interestExpense = 22,006
19,872
46,302
Interest Expense27,523
Earnings Before Interest and Taxes (EBIT)49,52947,395
Earnings Before Interest and Taxes (EBITDA)109,320
 
After tax Income (+$)
Income Before Tax19,872
Tax Provision--184
Net Income From Continuing Ops13,38120,056
Net Income18,779
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses437,287
Total Other Income/Expenses Net-29,65728,700
 

Technical Analysis of ANI Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ANI Pharmaceuticals Inc. The general trend of ANI Pharmaceuticals Inc is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ANI Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ANI Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 70.81.

The bearish price targets are: 57.44 > 57.15 > 54.62.

Tweet this
ANI Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ANI Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ANI Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ANI Pharmaceuticals Inc. The current macd is -0.18295451.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ANI Pharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for ANI Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the ANI Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
ANI Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartANI Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ANI Pharmaceuticals Inc. The current adx is 19.78.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell ANI Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
ANI Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ANI Pharmaceuticals Inc. The current sar is 67.40.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ANI Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ANI Pharmaceuticals Inc. The current rsi is 43.12. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
ANI Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartANI Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ANI Pharmaceuticals Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ANI Pharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
ANI Pharmaceuticals Inc Daily Stochastic Oscillator ChartANI Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ANI Pharmaceuticals Inc. The current cci is -124.6426608.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
ANI Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartANI Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ANI Pharmaceuticals Inc. The current cmo is -25.11126555.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ANI Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartANI Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ANI Pharmaceuticals Inc. The current willr is -82.10023866.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
ANI Pharmaceuticals Inc Daily Williams %R ChartANI Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ANI Pharmaceuticals Inc. The current atr is 1.424539.

ANI Pharmaceuticals Inc Daily Average True Range (ATR) ChartANI Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ANI Pharmaceuticals Inc. The current obv is 2,767,488.

ANI Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartANI Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ANI Pharmaceuticals Inc. The current mfi is 30.03.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
ANI Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartANI Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ANI Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

ANI Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ANI Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.118
Ma 20Greater thanMa 5066.634
Ma 50Greater thanMa 10065.374
Ma 100Greater thanMa 20059.878
OpenGreater thanClose65.050
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of ANI Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on ANI Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ANI Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ANI Pharmaceuticals Inc

I send you an email if I find something interesting about ANI Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about ANI Pharmaceuticals Inc.

Receive notifications about ANI Pharmaceuticals Inc in your mailbox!